Skip to content

VOR BIOPHARMA INC.

VOR

CIK 0001817229

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$2.64B
−495.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$144.51
−107.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$124.53M
Q1 May 2026
Cash
$169.87M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
54.19M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings